Saturn V Capital Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Saturn V Capital Management LLC
CIK #0001883601, 0001964437
CIK Period
0001883601 0001964437
Sector Form 13F Holdings Value ($M)
Alumis Inc 70.5
Amylyx Pharmaceuticals Inc 60.5
Abivax Sa 60.4
Vaxcyte Inc 47.9
Pharvaris NV 33.9
Immix Biopharma Inc 33.6
Celcuity Inc 32.2
Jazz Pharmaceuticals Inc 30.8
FS Development Corp 28.8
Arsanis Inc 26.7
UNUM Therapeutics Inc 24.1
Monopar Therapeutics 18.9
Dyne Therapeutics Inc 17.5
Adagio Therapeutics Inc 14.2
Candel Therapeutics Inc 14.2
Oculis Holding AG 13.7
OVID Therapeutics Inc 9.2
Inhibikase Therapeutics Inc 6.5
JATT Acquisition Corp 4.4
Alto Neuroscience Inc 2.0
Satellos Bioscience Inc 2.0
 
 
 
 
 
 
 
 
 
 
Prev | Page 1 | Next
EDGAR Form CIK 2011 - 2026
D [0001883601]
13F-HR [0001964437]
SC 13G [0001964437]
Form 13D/13G Filer Form 13D/13G Subject Filed
Saturn V Capital Management LP Monopar Therapeutics [2026-05-15]
Saturn V Capital Management LP Immix Biopharma Inc [2026-02-17]
Saturn V Capital Management LP X4 Pharmaceuticals Inc [2026-02-17]
Saturn V Capital Management LP KalVista Pharmaceuticals Inc [2024-02-12]
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com